BioPharm America 2019

Published on 13 June 2019

A unique partnering event that forms the nexus of discovery and realization of drug development, BioPharm America is now in its 12th year. The event creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size and stage, from mature to start-up. Additionally, it brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

Register to attend here

Edison clients will receive $200 for each conference using code EIRemember200

A primary focus of BioPharm America is the one-to-one meetings driven by partneringONE, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities.

The impetus behind this intensive business development activity is a two-day conference program that features thought leaders and executives from across the life science industry. To help bring attention to early-stage projects and small entrepreneurial companies, BioPharm America features special tracks specifically designed for start-ups and young companies to get on the radar of the global life science community and make the connections that matter. Leading pharmaceutical companies attend BioPharm America in search of innovation.

Engaging panel discussions cover topics of interest to dealmakers including licensing, investment and business development. Held in Boston each September, the event attracts 800+ delegates from over 500 companies who participate in 2,300+ scheduled one-to-one meetings. Additionally, BioPharm America is now part of Biotech Week Boston, providing concurrent events and highlights, which attracts over 4,500 life science leaders, scientists and innovators.

2019 company presentation committee

Murali-Gopalakrishnan Michal-Preminger Aaron-Schwartz Mark-Wolterz
Murali Gopalakrishnan, AbbVie, Senior Director and Global Head, Search and Evaluation Neuroscience Michal Preminger, Johnson & Johnson Innovation, East North America Head Aaron Schwartz, Novo Nordisk, Director of Search and Evaluation, Global Drug Discovery Mark Wolters, Bayer, Head of Early Licensing and Transactions

See who presented at BioPharm America 2018


Event: BioPharm America 2019
Date: 11–12 September 2019
Location: Boston Convention and Exhibition Center (BCEC), 415 Summer Street, Boston, MA 02210, USA
Why: The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

To attend: Book your tickets here or contact Yesenia Cortes

Share this with friends and colleagues